Trials / Recruiting
RecruitingNCT06259019
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
Site of Disease BIOmolecule Capture and Analysis in PATienTs With Established Coronary Disease undERgoing iNtracoronary Assessment
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- PlaqueTec Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this research, proposed and funded by PlaqueTec and co-ordinated by Papworth Trials Unit Collaboration, is to demonstrate the performance of the coronary artery blood sampling device (Liquid Biospy System, LBS) and establish its usefulness to collect a range of disease biomolecules from the coronary artery of interest. Using the data generated from extensive analysis of the blood samples, key biomarker data will be generated that will close a knowledge gap and facilitate the development of tailored treatments for coronary artery disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Liquid Biopsy System (LBS) | Coronary artery catheter designed to mix intra-arterial flow and simultaneously extract multiple blood samples from around the site of coronary disease within a vessel of interest. |
Timeline
- Start date
- 2023-09-14
- Primary completion
- 2027-12-01
- Completion
- 2028-02-01
- First posted
- 2024-02-14
- Last updated
- 2026-04-03
Locations
4 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06259019. Inclusion in this directory is not an endorsement.